hrcak mascot   Srce   HID

Acta Pharmaceutica, Vol. 60 No. 4, 2010.

Izvorni znanstveni članak
https://doi.org/10.2478/v10007-010-0031-x

Development and optimization of metoprolol succinate gastroretentive drug delivery system

SANJAY P. BOLDHANE ; Piramal Health Care Limited, Mumbai-400063, India
BHANUDAS S. KUCHEKAR ; Maharashtra Institute of Pharmacy, Pune-411038, India

Puni tekst: engleski, pdf (154 KB) str. 415-425 preuzimanja: 926* citiraj
APA 6th Edition
BOLDHANE, S.P. i KUCHEKAR, B.S. (2010). Development and optimization of metoprolol succinate gastroretentive drug delivery system. Acta Pharmaceutica, 60 (4), 415-425. https://doi.org/10.2478/v10007-010-0031-x
MLA 8th Edition
BOLDHANE, SANJAY P. i BHANUDAS S. KUCHEKAR. "Development and optimization of metoprolol succinate gastroretentive drug delivery system." Acta Pharmaceutica, vol. 60, br. 4, 2010, str. 415-425. https://doi.org/10.2478/v10007-010-0031-x. Citirano 23.02.2019.
Chicago 17th Edition
BOLDHANE, SANJAY P. i BHANUDAS S. KUCHEKAR. "Development and optimization of metoprolol succinate gastroretentive drug delivery system." Acta Pharmaceutica 60, br. 4 (2010): 415-425. https://doi.org/10.2478/v10007-010-0031-x
Harvard
BOLDHANE, S.P., i KUCHEKAR, B.S. (2010). 'Development and optimization of metoprolol succinate gastroretentive drug delivery system', Acta Pharmaceutica, 60(4), str. 415-425. doi: https://doi.org/10.2478/v10007-010-0031-x
Vancouver
BOLDHANE SP, KUCHEKAR BS. Development and optimization of metoprolol succinate gastroretentive drug delivery system. Acta Pharm. [Internet]. 2010 [pristupljeno 23.02.2019.];60(4):415-425. doi: https://doi.org/10.2478/v10007-010-0031-x
IEEE
S.P. BOLDHANE i B.S. KUCHEKAR, "Development and optimization of metoprolol succinate gastroretentive drug delivery system", Acta Pharmaceutica, vol.60, br. 4, str. 415-425, 2010. [Online]. doi: https://doi.org/10.2478/v10007-010-0031-x

Sažetak
Metoprolol succinate (MS) gastroretentive (GR) controlled release system was formulated to increase gastric residence time leading to improved drug bioavailability. Box-Behnken model was followed using novel combinations of sodium alginate (SA), sodium carboxymethylcellulose (NaCMC), magnesium alumino metasilicate (MAS) as independent variables. Floating lag time (Flag), t25, t50, t75, diffusion exponent as dependent variables revealed that the amount of SA, NaCMC and MAS have a significant effect (p < 0.05) on t25, t50, t75 and Flag. MSGR tablets were prepared and evaluated for mass, thickness, hardness, friability, drug content and floating property. Tablets were studied for dissolution for 24 h and exhibited controlled release of MS with floating for 16 h. The release profile of the optimized batch MS01 fitted first-order kinetics (R2 = 0.9868, n = 0.543), indicating non-Fickian diffusion or anomalous transport by diffusion and swelling.

Ključne riječi
metoprolol succinate; gastroretention; Box-Behnken design; floating tablets; release kinetics; controlled release

Hrčak ID: 59306

URI
https://hrcak.srce.hr/59306

[hrvatski]

Posjeta: 1.152 *